Pacrint 150 Capsule contains Pancreatin 150mg, a combination of digestive enzymes including amylase, lipase, and protease, designed to support efficient digestion of carbohydrates, fats, and proteins. It is particularly useful in conditions of pancreatic insufficiency, such as chronic pancreatitis, cystic fibrosis, or after pancreatic surgery.
This formulation helps improve nutrient absorption, reduces bloating, indigestion, and steatorrhea, and supports overall gastrointestinal health. Patients with enzyme deficiency can achieve better digestion and enhanced quality of life with regular use under medical guidance.
Pacrint 150 Capsule belongs to the gastrointestinal care segment, ensuring consistent demand among hospitals, clinics, gastroenterology centers, and PCD pharma franchise networks. Its clinically proven efficacy and patient-friendly formulation provide franchise partners a competitive advantage in the digestive health market.
With increasing prevalence of digestive disorders and enzyme deficiencies, Pacrint 150 Capsule represents a strong B2B opportunity. It is ideal for PCD distribution, institutional supply, and export markets, making it a high-demand, high-margin addition to any pharma portfolio focusing on gastrointestinal and digestive health therapies.